All Relations between ci and Sarcopenia

Publication Sentence Publish Date Extraction Date Species
Kittipitch Bannangkoon, Keerati Hongsakul, Teeravut Tubtawee, Natee Ina, Ply Chichareo. Association of myosteatosis with treatment response and survival in patients with hepatocellular carcinoma undergoing chemoembolization: a retrospective cohort study. Scientific reports. vol 13. issue 1. 2023-03-09. PMID:36894658. in the multivariable cox regression analysis, patients with myosteatosis or sarcopenia had higher risk of all-cause mortality than their counterparts (adjusted hazard ratio [hr] for myosteatosis versus no myosteatosis 1.66, 95% ci 1.37-2.01, adjusted hr for sarcopenia versus no sarcopenia 1.26, 95% ci 1.04-1.52). 2023-03-09 2023-08-14 Not clear
Yu-Hsiang Tsai, Wan-Ming Chen, Ming-Chih Chen, Ben-Chang Shia, Szu-Yuan Wu, Chun-Chi Huan. Effect of Pre-Existing Sarcopenia on Oncological Outcomes for Oral Cavity Squamous Cell Carcinoma Undergoing Curative Surgery: A Propensity Score-Matched, Nationwide, Population-Based Cohort Study. Cancers. vol 14. issue 13. 2023-03-08. PMID:35805020. in multivariate cox regression analyses, the adjusted hazard ratio (ahr, 95% confidence interval [ci]) of all-cause mortality for ocscc with and without pre-existing sarcopenia was 1.15 (1.11−1.21, p < 0.0001). 2023-03-08 2023-08-16 Not clear
Jui-An Lin, Jin-De Hou, Szu-Yuan W. Effect of Sarcopenia on Mortality in Type 2 Diabetes: A Long-Term Follow-Up Propensity Score-Matched Diabetes Cohort Study. Journal of clinical medicine. vol 11. issue 15. 2023-03-08. PMID:35956041. according to both univariate and multivariate cox regression analyses, the adjusted hazard ratios (ahrs; 95% confidence interval [ci]) of all-cause death for the sarcopenia diabetes group compared with the control group: 1.35 (1.33−1.38; p < 0.001). 2023-03-08 2023-08-16 Not clear
Dara Aldisi, Mahmoud M A Abulmeaty, Tafany A Alsaawi, Abeer S Alorf, Gadah Mujlli, Atheer M Alshahrani, Rajwa M Alahmari, Mohammed Alquraishi, Nasser M Al-Daghri, Nawaf W Alruwaili, Shaun Sabic. Diagnostic Value of Inflammatory Markers in Elderly Arab Women with Sarcopenia. Diagnostics (Basel, Switzerland). vol 12. issue 10. 2023-03-08. PMID:36291982. lastly, participants with a tnf-α > 71.2 were five times more likely to have sarcopenia [(or = 5.85), 95% ci: 1.07−32.08; p = 0.04]. 2023-03-08 2023-08-16 human
Erik Haehl, Luisa Alvino, Alexander Rühle, Jiadai Zou, Alexander Fabian, Anca-Ligia Grosu, Nils H Nicola. Sarcopenia as a Prognostic Marker in Elderly Head and Neck Squamous Cell Carcinoma Patients Undergoing (Chemo-)Radiation. Cancers. vol 14. issue 22. 2023-03-08. PMID:36428629. os was significantly deteriorated in sarcopenic patients with a median of 23 vs. 91 months (logrank p = 0.002) (hr 1.79, ci 1.22−2.60, p = 0.003) and sarcopenia remained an independent prognostic factor for reduced os in the multivariate analysis (hr 1.64, ci 1.07−2.52, p = 0.023). 2023-03-08 2023-08-16 Not clear
Goh Eun Chung, Sohee Oh, Dong-Won Ahn, Su Hwan Kim, Yong Jin Jung, Ji Won Kim, Byeong Gwan Kim, Kook Lae Lee, Ji Bong Jeon. Effects of additive interactions among obesity, visceral adiposity, and sarcopenia on nonalcoholic fatty liver disease. Scientific reports. vol 13. issue 1. 2023-03-03. PMID:36869158. the or of interaction between obesity and sarcopenia affecting nafld was 8.46 (95% ci: 7.01-10.21). 2023-03-03 2023-08-14 human
Goh Eun Chung, Sohee Oh, Dong-Won Ahn, Su Hwan Kim, Yong Jin Jung, Ji Won Kim, Byeong Gwan Kim, Kook Lae Lee, Ji Bong Jeon. Effects of additive interactions among obesity, visceral adiposity, and sarcopenia on nonalcoholic fatty liver disease. Scientific reports. vol 13. issue 1. 2023-03-03. PMID:36869158. the or of interaction between sarcopenia and visceral adiposity affecting nafld was 7.25 (95% ci: 6.04-8.71), however, there was no significant additive interaction with reri = 0.87 (95% ci: -0.76 to 2.51). 2023-03-03 2023-08-14 human
Francesco Pegreffi, Alice Balestra, Orazio De Lucia, Lee Smith, Mario Barbagallo, Nicola Verones. Prevalence of Sarcopenia in Knee Osteoarthritis: A Systematic Review and Meta-Analysis. Journal of clinical medicine. vol 12. issue 4. 2023-02-25. PMID:36836065. pooling the data of the studies included that the prevalence of sarcopenia in knee oa was more than two times higher than in the control group (or = 2.07; 95%ci: 1.43-3.00; i 2023-02-25 2023-08-14 human
Konstantinos Prokopidis, Panagiotis Giannos, Jean Yves Reginster, Olivier Bruyere, Mirko Petrovic, Antonio Cherubini, Konstantinos K Triantafyllidis, Konstantinos S Kechagias, Yannis Dionyssiotis, Matteo Cesari, Kinda Ibrahim, David Scott, Mario Barbagallo, Nicola Verones. Sarcopenia is associated with a greater risk of polypharmacy and number of medications: a systematic review and meta-analysis. Journal of cachexia, sarcopenia and muscle. 2023-02-13. PMID:36781175. sarcopenia was associated with a higher prevalence of polypharmacy (odds ratio [or]: 1.65, 95% confidence interval [ci] [1.23, 2.20], i 2023-02-13 2023-08-14 Not clear
Anna Edwards, Brett G M Hughes, Teresa Brown, Judith Baue. Prevalence and Impact of Computed Tomography-Defined Sarcopenia on Survival in Patients with Human Papillomavirus-Positive Oropharyngeal Cancer: A Systematic Review. Advances in nutrition (Bethesda, Md.). vol 13. issue 6. 2023-02-11. PMID:36774036. these studies demonstrated the cumulative prevalence of sarcopenia for opc+ patients to be 42.9% (95% ci: 37.8%, 47.9%). 2023-02-11 2023-08-14 human
Paola Bonavolontà, Giovanni Improta, Giovanni Dell'Aversana Orabona, Federica Goglia, Vincenzo Abbate, Alfonso Sorrentino, Sara Piloni, Giovanni Salzano, Giorgio Iaconetta, Luigi Califan. Evaluation of sarcopenia and sarcopenic obesity in patients affected by oral squamous cell carcinoma: A retrospective single-center study. Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery. 2023-02-04. PMID:36739189. within the limitations of the study, in this sample, sarcopenia did not seem to cause a statistically significant reduction in the overall survival in patients with oral squamous cell carcinoma (log rank χ2 = 3.67, p = 0.055; hr 0.996, 95% ci 0.732-1.354, p = 0.979), however, sarcopenic obesity showed a meaningful negative prognostic impact on it (log rank χ2 = 5.71, p = 0.017; hr 0.985, 95% ci 0.424-2.286, p = 0.972). 2023-02-04 2023-08-14 Not clear
Beverly Wen-Xin Wong, Win Pa Pa Thu, Yiong Huak Chan, Susan Jane Sinclair Logan, Jane A Cauley, Eu-Leong Yon. Association of sarcopenia with important health conditions among community-dwelling Asian women. PloS one. vol 18. issue 1. 2023-01-30. PMID:36716336. osteoporosis (aor: 1.74, 95% ci: 1.02, 2.94) and t2dm (aor: 1.98, 95% ci: 1.14, 3.42) was positively associated with awgs- and fnih-defined sarcopenia respectively, while hypertension was not, after adjustment for age, ethnicity, education levels and menopausal status. 2023-01-30 2023-08-14 human
Luana Aparecida Soares, Liliana Pereira Lima, Ana Caroline Negreiros Prates, Arthur Nascimento Arrieiro, Leonardo Augusto Da Costa Teixeira, Tamiris Campos Duarte, Jousielle Márcia Dos Santos, Vanessa Kelly da Silva Lage, Fabiana Angélica de Paula, Henrique Silveira Costa, Pedro Henrique Scheidt Figueiredo, Vike Maria Tamar Leão de Almeida, Núbia de Sara Abreu, Sabrina Paula Costa, Franciane Pereira Brant, Rávylla Rúbia Lima, Ronaldo Luis Thomasini, Leani Souza Máximo Pereira, Fabiana Souza Máximo Pereira, Adriana Netto Parentoni, Núbia Carelli Pereira de Avelar, Amanda Aparecida Oliveira Leopoldino, Vanessa Amaral Mendonça, Ana Cristina Rodrigues Lacerd. Accuracy of handgrip and respiratory muscle strength in identifying sarcopenia in older, community-dwelling, Brazilian women. Scientific reports. vol 13. issue 1. 2023-01-27. PMID:36707661. mep (or 0.98 [95%ci 0.97, 1.00], p = 0.023) and hgs (or 0.82 [95% ci 0.75, 0.90], p < 0.001) were independent factors for sarcopenia in older. 2023-01-27 2023-08-14 human
Yusheng Guo, Yanqiao Ren, Licheng Zhu, Lian Yang, Chuansheng Zhen. Association between sarcopenia and clinical outcomes in patients with hepatocellular carcinoma: an updated meta-analysis. Scientific reports. vol 13. issue 1. 2023-01-17. PMID:36650190. the pooled prevalence of sarcopenia in hcc patients was 41.7% (95% ci 36.2-47.2%). 2023-01-17 2023-08-14 Not clear
Yusheng Guo, Yanqiao Ren, Licheng Zhu, Lian Yang, Chuansheng Zhen. Association between sarcopenia and clinical outcomes in patients with hepatocellular carcinoma: an updated meta-analysis. Scientific reports. vol 13. issue 1. 2023-01-17. PMID:36650190. results demonstrated that sarcopenia was significantly associated with impaired os (hr: 1.93, 95% ci 1.73-2.17, p < 0.001), higher risk of tumor recurrence (hr: 1.75, 95% ci 1.56-1.96, p < 0.001), lower objective response rate (or: 0.37 95% ci 0.17-0.81, p = 0.012), and more drug-related adverse events (or: 2.23, 95% ci 1.17-4.28, p = 0.015) in hcc patients. 2023-01-17 2023-08-14 Not clear
Pedro de Pablos-Rodríguez, Tasmania Del Pino-Sedeño, Diego Infante-Ventura, Aythami de Armas-Castellano, Miguel Ramírez Backhaus, Juan Francisco Loro Ferrer, Pedro de Pablos-Velasco, Antonio Rueda-Domínguez, María M Trujillo-Martí. Prognostic Impact of Sarcopenia in Patients with Advanced Prostate Carcinoma: A Systematic Review. Journal of clinical medicine. vol 12. issue 1. 2023-01-08. PMID:36614862. sarcopenia was borderline associated with a shorter overall survival (hr = 1.20, 95% ci: 1.01, 1.44, p = 0.04, i 2023-01-08 2023-08-14 human
Ching-Ming Chiu, Kuen-Cheh Yang, Hao-Hsiang Chang, Chia-Wen Lu, Chien-Hsieh Chiang, Kuo-Chin Huan. Dose-Dependent Association Between Sarcopenia and Moderate-to-Severe Thoracic Vertebral Fragility Fracture in Older Adults. Gerontology. 2023-01-02. PMID:36592622. in the logistical regression model adjusted for confounding factors, sarcopenia plus severe sarcopenia was identified as a risk factor of moderate-to-severe thoracic vertebral fragility fracture (odds ratio(or) = 3.29, 95% ci 1.23-8.78, p = 0.018). 2023-01-02 2023-08-14 human
Ching-Ming Chiu, Kuen-Cheh Yang, Hao-Hsiang Chang, Chia-Wen Lu, Chien-Hsieh Chiang, Kuo-Chin Huan. Dose-Dependent Association Between Sarcopenia and Moderate-to-Severe Thoracic Vertebral Fragility Fracture in Older Adults. Gerontology. 2023-01-02. PMID:36592622. we further classified the participants into normal, sarcopenia, and severe sarcopenia and found that sarcopenia and severe sarcopenia had a dose-dependent association with prevalence of thoracic vertebral fragility fractures with or of 2.56 (95% ci: 0.66-9.91) and 4.04 (95% ci: 1.24-13.20), respectively; p for trend = 0.014. 2023-01-02 2023-08-14 human
Ya-Huang Lin, Kwo-Chen Lee, Ya-Ling Tzeng, Yun-Ping Lin, Wen-Miao Liu, Shu-Hua L. Comparison of four screening methods for sarcopenia among community-dwelling older adults: A diagnostic accuracy study. Geriatric nursing (New York, N.Y.). vol 49. 2022-12-21. PMID:36543041. relative to the "bigger," a significant association between sarcopenia and the yubi-wakka test ("just fits" or: 4.1, 95% ci: 1.57-10.98; "small" or: 27.5, 95% ci: 10.14-74.55) was observed. 2022-12-21 2023-08-14 human
Hao Zhang, Li Zhang, Yi Wang, Ji Zou, Ting Zhan. Sarcopenia Predicts Prognosis of Patients Undergoing Liver Resection for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Nutrition and cancer. 2022-12-20. PMID:36537813. the results of meta-analysis showed that sarcopenia would increase postoperative complications (or = 1.30, 95%ci 1.03 ∼ 1.65, 2022-12-20 2023-08-14 Not clear